Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Defining a prognostic score based on O6-methylguanine-DNA methyltransferase cut-off methylation level determined by pyrosequencing in patients with glioblastoma multiforme.
De Carlo E, Gerratana L, De Maglio G, Buoro V, Cortiula F, Gurrieri L, Isola M, Fasola G, Puglisi F, Pizzolitto S, Rizzato S. De Carlo E, et al. Among authors: gerratana l. J Neurooncol. 2018 Dec;140(3):559-568. doi: 10.1007/s11060-018-2981-7. Epub 2018 Aug 21. J Neurooncol. 2018. PMID: 30132165
Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer.
Davis AA, Gerratana L, Clifton K, Medford AJ, Velimirovic M, Hensing WL, Bucheit L, Shah AN, D'Amico P, Reduzzi C, Zhang Q, Dai CS, Denault EN, Bagegni NA, Opyrchal M, Ademuyiwa FO, Bose R, Gradishar WJ, Behdad A, Ma CX, Bardia A, Cristofanilli M. Davis AA, et al. Among authors: gerratana l. EBioMedicine. 2022 Dec;86:104316. doi: 10.1016/j.ebiom.2022.104316. Epub 2022 Nov 1. EBioMedicine. 2022. PMID: 36332363 Free PMC article.
Measures of outcome in metastatic breast cancer: insights from a real-world scenario.
Bonotto M, Gerratana L, Poletto E, Driol P, Giangreco M, Russo S, Minisini AM, Andreetta C, Mansutti M, Pisa FE, Fasola G, Puglisi F. Bonotto M, et al. Among authors: gerratana l. Oncologist. 2014 Jun;19(6):608-15. doi: 10.1634/theoncologist.2014-0002. Epub 2014 May 2. Oncologist. 2014. PMID: 24794159 Free PMC article.
Pattern of metastasis and outcome in patients with breast cancer.
Gerratana L, Fanotto V, Bonotto M, Bolzonello S, Minisini AM, Fasola G, Puglisi F. Gerratana L, et al. Clin Exp Metastasis. 2015 Feb;32(2):125-33. doi: 10.1007/s10585-015-9697-2. Epub 2015 Jan 29. Clin Exp Metastasis. 2015. PMID: 25630269
In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis.
Bulfoni M, Gerratana L, Del Ben F, Marzinotto S, Sorrentino M, Turetta M, Scoles G, Toffoletto B, Isola M, Beltrami CA, Di Loreto C, Beltrami AP, Puglisi F, Cesselli D. Bulfoni M, et al. Among authors: gerratana l. Breast Cancer Res. 2016 Mar 9;18(1):30. doi: 10.1186/s13058-016-0687-3. Breast Cancer Res. 2016. PMID: 26961140 Free PMC article.
Do platinum salts fit all triple negative breast cancers?
Gerratana L, Fanotto V, Pelizzari G, Agostinetto E, Puglisi F. Gerratana L, et al. Cancer Treat Rev. 2016 Jul;48:34-41. doi: 10.1016/j.ctrv.2016.06.004. Epub 2016 Jun 11. Cancer Treat Rev. 2016. PMID: 27343437 Review.
106 results